Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) clinical trials

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

This study is testing a new treatment called anti-COVID-19 immunoglobulin (hIVIG) for adults recently diagnosed with COVID-19 who don't need hospital care. Researchers want to see if hIVIG is safe and effective in preventing severe illness compared to a dummy treatment (placebo).